Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note Payable - Additional Information (Detail)

Note Payable - Additional Information (Detail)				3 Months Ended		9 Months Ended	12 Months Ended
Note Payable - Additional Information (Detail)	May 20, 2016 USD ($)	Apr. 22, 2016 USD ($)	Jun. 30, 2015 USD ($) Installments	Feb. 28, 2017 USD ($)	Feb. 29, 2016 USD ($)	Mar. 31, 2016 USD ($)	Nov. 30, 2016 USD ($)	Aug. 26, 2016 USD ($)	Jul. 01, 2016 USD ($)
Debt Instrument [Line Items]
Note payable				$ 7,353,903			$ 7,819,750
Debt instrument payment				500,000	$ 75,423
Gain on extinguishment of debt							300,593
Notes payable, interest expense				121,988	0
Interest expense				297,044	261,334
Debt issuance costs				378,785
Amortization of debt issuance costs				34,153	0
Texas Capital Bank National Association [Member] \| Amended And Restated Promissory Notes [Member]
Debt Instrument [Line Items]
Principal paid				1,133,000			$ 633,000
Interest expense				$ 102,488	0
TCB and CrowdOut Capital LLC [Member]
Debt Instrument [Line Items]
Subordinated loan	$ 650,000
TCB and CrowdOut Capital LLC [Member] \| Subordinated Debt [Member]
Debt Instrument [Line Items]
Line of credit facility, interest rate	12.00%
Line of credit facility, expiration date	Jul. 31, 2021
Line of credit facility, description				Per a promissory note dated May 20, 2016 between the Company and CrowdOut, interest at 12% per annum on the principal sum of $650,000 is payable monthly with a maturity date of July 2021, at which time, the principal amount of $650,000 is payable.
Line of credit facility, frequency of payment				Monthly
Interest expense				$ 19,500	0
Notes Payable [Member]
Debt Instrument [Line Items]
Asset purchase agreement commencement date			Jul. 31, 2015
Asset purchase agreement closing date			Jun. 30, 2019
Notes payable, interest expense					$ 14,391
Senior Credit Facilities [Member] \| Texas Capital Bank National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit facility, description				Subject to the terms of the Agreement, on May 20, 2016, TCB advanced the Company $100.00. On July 1, 2016, TCB advanced the remaining principal amount of $7,999,900 per a promissory note dated May 20, 2016 between the Company and TCB, at a rate of 3.75% per annum plus LIBOR, payable monthly with a maturity date of July 2021.
Line of credit facility, frequency of payment				Monthly
Line of credit facility, interest rate description				3.75% per annum plus LIBOR
Senior Credit Facilities [Member] \| Texas Capital Bank National Association [Member] \| Promissory Notes [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit facility, amount advanced									$ 7,999,900
Senior Credit Facilities [Member] \| London Interbank Offered Rate (LIBOR) [Member] \| Texas Capital Bank National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Term loan, maximum borrowing capacity	$ 8,000,000
Line of credit facility, amount advanced	$ 100.00
Line of credit facility, interest rate	3.75%			3.75%			3.75%
Line of credit facility, expiration date	Jul. 31, 2021
Amended Senior Credit Facility [Member] \| Texas Capital Bank National Association [Member] \| Amended And Restated Promissory Notes [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit facility, amount advanced								$ 2,133,433
Asset Purchase Agreement [Member]
Debt Instrument [Line Items]
Note payable			$ 1,300,000
Asset Purchase Agreement [Member] \| CytoMedical [Member]
Debt Instrument [Line Items]
Debt instrument payment		$ 778,287				$ 269,443
Asset Purchase Agreement [Member] \| Notes Payable [Member]
Debt Instrument [Line Items]
Number of monthly installments \| Installments			48
Repayment interval				Monthly
Monthly installment amount			$ 29,938
Annual interest rate			5.00%